Celine Merlin

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.

Journal: Oncoimmunology

Published: May 29, 2025

Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.

Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: June 14, 2023

Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.

Journal: Oncoimmunology

Published: March 27, 2023

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.

Journal: Antioxidants (Basel, Switzerland)

Published: February 02, 2023

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.

Journal: Pharmaceutics

Published: October 24, 2022

Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.

Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.

Journal: Cells

Published: September 16, 2021

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.

Journal: Cancers

Published: November 06, 2020

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.

Journal: Acta neuropathologica communications

Published: October 21, 2015

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study.

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study.

Journal: Neurobiology of aging

Published: February 05, 2015

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.

Journal: Acta neuropathologica

Published: February 10, 2014

Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients.

Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients.

Journal: Neurobiology of aging

Published: October 30, 2012

Internalization of mRNA lipoplexes by dendritic cells.

Internalization of mRNA lipoplexes by dendritic cells.

Journal: Molecular pharmaceutics

Published: August 17, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026